Crescent Biopharma, Inc. (CBIO) — Cash Flow Reinvestment Rate
Crescent Biopharma, Inc. (CBIO) has a Cash Flow Reinvestment Rate of 0.00x as of September 2015, reinvesting $58.39K (capex $58.39K ) from operating cash flow of $13.56 Million. See cash generation quality of Crescent Biopharma, Inc. to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Crescent Biopharma, Inc. Cash Flow Reinvestment Rate (2011–2011)
Historical reinvestment intensity for Crescent Biopharma, Inc. across 1 annual periods. For the full cash flow conversion analysis, see Crescent Biopharma, Inc. cash conversion from operations.
Annual Cash Flow Reinvestment Rate for Crescent Biopharma, Inc. (2011–2011)
Year-by-year capital reinvestment analysis for Crescent Biopharma, Inc.. See financial flexibility index of Crescent Biopharma, Inc. to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2011 | 0.01x | $182.44K | $13.85 Million | $182.44K | — |